课题基金 / 基金详情

Clinical Sciences Core (Core C)

Clinical Sciences Core (Core C)
临床科学核心(核心 C)
批准号:
10153672
负责人:
David W Haas
金额:
$66.37万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-04-01 至 2025-04-30

项目摘要

项目成果

David W Haas的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clinical Sciences Core – PROJECT SUMMARY The Tennessee Center for AIDS Research (CFAR) is located in the Southeastern US, the region with both the greatest number of new HIV-1 infections, and of persons living with HIV. The CFAR is a four-way partnership between a research-intensive institution (Vanderbilt University Medical Center), a historically black medical college (Meharry Medical College), an academically engaged state health department (Tennessee Department of Health), and an highly evolved HIV-focused community-based organization (Nashville CARES). This CFAR's institutional and community environment is rich in opportunity, and with a culture of engagement and collaboration. The Clinical Sciences Core (CSC) fills major gaps in the local research environment, and in so doing supports the mission of the CFAR to reduce the overall burden of HIV/AIDS through the pursuit of National Institutes of Health high priorities for HIV/AIDS research, with the ultimate goal of ending the HIV epidemic. Access to research study participants and associated biospecimens, and to large clinical cohort datasets, are essential for high-quality clinical and translational HIV research. Since this CFAR was established in 2015, the CSC has been integral to its success. The CSC is essential for early stage investigators on their path toward independent extramural funding, which equips the next generation of research scientists while also serving to expand this CFAR's HIV research portfolio and funding base. Building upon the expertise and collective infrastructure of the CFAR, coupled with the addition of a strong, established community partner in CARES, we will pursue the following three specific aims: 1) To propel the use of observational databases for high impact HIV clinical and translational research; 2) To support research projects that require access to study volunteers and associated biological specimens, and; 3) To support research opportunities for MMC investigators, including team science.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt CTU SARS-CoV-2 Supplement
Clinical Sciences Core (Core C)
Clinical Sciences Core (Core C)
Pharmacogenomics of HIV Therapy
  • 批准号:
    9100608
  • 项目类别:
  • 资助金额:
    $8.3万
  • 财政年份:
    2008
  • 负责人:
    David W Haas
  • 依托单位: